We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Diagnostics

Image: LucenceINSIGHT enables early cancer detection through a single blood test (Photo courtesy of Freepix)

ctDNA-Based Liquid Biopsy Test Screens for 10 Common Cancers in Single Blood Draw

A pioneering multi-cancer early detection (MCED) test now offers the potential for early cancer detection by screening for the risk of up to 10 cancers in a simple blood draw. More...
11 May 2023
Image: Epi+Gen CHD is a patented next generation test that assesses near-term (3-year) risk for a heart attack (Photo courtesy of Cardio Diagnostics)

New Diagnostic Approach Combines DNA Testing With AI Analysis for Coronary Heart Disease Risk Assessment

A novel test merges epigenetics, genetics, high-throughput computing, and artificial intelligence to pinpoint individuals at risk for coronary heart disease, a critical factor in delivering cost-effective health care to adults. More...
10 May 2023
DIASOURCE (A Biovendor Company)
Image: ColoNode is a new type of biomarker test for colorectal cancer (Photo courtesy of Hiloprobe)

Gene Expression Test Detects and Characterizes Tumor Cells in Lymph Node after Surgery

A new gene expression signature test can enhance the detection of nodal metastasis in patients with colorectal cancer, leading to better disease staging. More...
10 May 2023
Image: The BioCode MDx-3000 automated system maximizes sample throughput without compromising quality (Photo courtesy of Applied BioCode)

Automated Molecular Diagnostic System Transforms Lab Experience

An automated molecular diagnostic system offers high sample throughput without sacrificing quality and facilitates efficient and precise testing for infectious diseases using various assays. More...
10 May 2023
Image: Avantect test has shown a strong performance for early detection of pancreatic cancer with epigenomics (Photo courtesy of Freepik)

AI-Powered Blood Test Enables Early Detection of Pancreatic Cancer in High-Risk Patients

A simple DNA-based blood test, designed for patients at high risk for pancreatic cancer, including those newly diagnosed with type 2 diabetes aged 50 and above, can identify pancreatic cancer in its earliest stages. More...
10 May 2023
Image: Cyto-Mine single cell analysis system (Photo courtesy of Sphere Fluidics)

Breakthrough Microfluidic Device Could Revolutionize Diagnosis and Treatment of Cancer

A new European initiative seeks to advance microfluidic technology for isolating and cultivating circulating tumor cells, which could potentially predict cancer metastasis and direct treatment strategies. More...
10 May 2023
Bladder EpiCheck is the first urine biomarker methylation test of its kind to be FDA cleared for NMIBC surveillance (Photo courtesy of Nucleix)

First Of Its Kind Urine Biomarker Methylation Test Predicts Bladder Cancer Recurrence

A simple, objective urine test for recurrent bladder cancer that analyzes subtle disease-specific changes in DNA methylation markers, with high sensitivity and specificity, is set to become commercially available in the U.S. More...
09 May 2023
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Automated Biochemical Analyzer
iBC 900


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2025 Globetech Media. All rights reserved.